• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE PRIME EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE PRIME EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1011711-23
Device Problems Deflation Problem (1149); Difficult or Delayed Positioning (1157); Difficult to Remove (1528)
Patient Problems Cardiac Arrest (1762); Death (1802); Respiratory Distress (2045); Thrombosis (2100)
Event Date 12/17/2013
Event Type  Death  
Manufacturer Narrative
(b)(4).It is indicated that the device is not returning for evaluation; therefore, a failure analysis of the complaint device could not be completed.A review of the lot history record revealed no non-conformances that would have contributed to the reported event.The results of the query of similar incidents in the complaint handling database for this lot did not indicate a manufacturing issue.The reported patient effects of thrombosis and death are known observed and potential patient effects as listed in the xience prime everolimus eluting coronary stent system instructions for use.Based on the reviewed information, no product deficiency was identified.
 
Event Description
It was reported that using a femoral the artery access approach during a procedure of the left main bifurcation and calcified circumflex ostium a rota floppy wire was positioned and successful rotablation with a 1.25 mm burr in the left main to circumflex was performed; followed by 1.75 mm burr with partial success.A balance guide wire was advanced to the circumflex and balloon dilatation completed to the ostium and distal left main with a 2.5 and 3.0 mm balloons.The rota wire was removed and a second balance guide wire was advanced to the left anterior descending (lad).The 3.0 x 8 mm xience prime stent was deployed in the proximal lad without issue and well inflated at 16 atmosphere (atm).A second 4.0 x 23 mm xience prime stent was positioned from the ostium of the left main to overlap with the 3.0 x 8 mm xience prime and the 4.0 x 23 mm was quickly inflated to 18 atm; a waist was observed just distal to the bifurcation in the distal part of the stent.It was noted that the balloon remained partially inflated at the distal end and could not be deflated.Unsuccessful attempts to deflate the balloon were made using an indeflator for 20-30 seconds and then using a 15 ml syringe.The balloon was removed from the anatomy with a slight tug while partially inflated.After removal it was noted the distal end of the balloon was observed to be bunched; outside the anatomy the nurse was able to inflate the balloon, however, it could not be deflated.
 
Manufacturer Narrative
(b)(4).Event description continued: the stent was post dilated but the waist remained at the level of the bifurcation.Approximately 2 hours post stenting procedure while in the cath lab the patient began to experience cardiac arrest; a code was initiated, the patient was intubated, cardiopulmonary resuscitation (cpr) and multiple defibrillations, and medications/drugs used for intervention, however, the patient subsequently died; the cause of death was not provided.Additionally, it was noted that thrombosis was seen in the stent and extending into the circumflex and was exported.No additional information was provided.Concomitant products: guide wire: rota floppy; balance.The stent remains in the anatomy.The customer reported the stent delivery system (sds) was discarded.Investigation is not yet complete.A follow-up report will be submitted with all relevant information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE PRIME EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 462
Manufacturer (Section G)
CLONMEL, IRELAND REG# 9616693
abbott vascular
26531 ynez road
temecula CA 92591 462
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key3569016
MDR Text Key11419129
Report Number2024168-2014-00234
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial,Followup
Report Date 12/18/2013
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/10/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/08/2015
Device Catalogue Number1011711-23
Device Lot Number3073141
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/20/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/01/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age78 YR
Patient Weight54
-
-